Biomarkers for diagnosis in thoracic aortic disease: CON

Cardiology Clinics

Volumn 28, Issue 2, 2010, Pages 213-220

  Farkas, Emily A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Disease state; Disease trait; Thoracic aortic aneurysm

Indexed keywords

BIOLOGICAL MARKER; D DIMER; FIBRILLIN 1; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

DISEASE COURSE; GENOMICS; HEALTH CARE DELIVERY; HUMAN; METABOLOMICS; PREDICTION; PRIORITY JOURNAL; PROTEOMICS; REVIEW; THORACIC AORTA ANEURYSM; AORTIC ANEURYSM, THORACIC; DIFFERENTIAL DIAGNOSIS; GENETIC SCREENING; GENETICS; METABOLISM; PROCEDURES; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX;

AORTIC ANEURYSM, THORACIC; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; GENETIC TESTING; HUMANS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 77952660924     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2010.01.018     Document Type: Review

References (50)

1. Downing G. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Biomarkers definitions working group. Clin Pharmacol Ther 2001, 69(3):49-95.
2. Vasan R.S. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006, 113(19):2335-2362.
3. Dotsenko O., Chackathayil J., Jeetesh V., et al. Candidate circulating biomarkers for the cardiovascular disease continuum. Curr Pharm Des 2008, 14(24):2445-2461.
4. Lee J.W., Figeys D., Vasilescu J. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers. Adv Cancer Res 2007, 96:269-298.
5. Fox N., Growdon J.H. Biomarkers and surrogates. Neuro Rx 2004, 1:181.
6. Loeys B.L., Chen J., Neptune E.R., et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive, and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005, 37:275-281.
7. Dean J.C. Marfan syndrome: clinical diagnosis and management. Eur J Hum Genet 2007, 15(7):724-733.
8. De Paepe A., Devereux R.B., Dietz H.C. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996, 62:417-426.
9. Montgomery R.A., Geraghty M.T., Bull E. Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome. Am J Hum Genet 1998, 63:1703-1711.
10. Attias D., Stheneur C., Roy C., et al. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation 2009, 120:2541-2549.
11. Guo D., Hasham S., Kuang S.Q., et al. Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation 2001, 103:2461-2468.
12. Hasham S.N., Willing M.C., Guo D.C., et al. Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25. Circulation 2003, 107:3184-3190.
13. Milewicz, et al. Genetic basis of thoracic aortic aneurysms and dissections. Acute aortic disease 2007, 99-124. Informa Healthcare, New York. J.A. Elefteriades (Ed.).
14. Hasham S.N., Lewin M.R., Tran V.T., et al. Nonsyndromic genetic predisposition to aortic dissection: a newly recognized, diagnosable, and preventable occurrence in families. Ann Emerg Med 2006, 7:11-20.
15. Absi T.S., Sundt T.M., Tung W.S. Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease. J Thorac Cardiovasc Surg 2003, 126:344-357.
16. Golledge J., Muller J., Daugherty A., et al. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 2006, 26:2605-2613.
17. Golledge J., Wolanski P., Parr A., et al. Measurement and determinants of infrarenal aortic thrombus volume. Eur Radiol 2008, 18:1987-1994.
18. Golledge J., Tsao P.S., Dalman R.L., et al. Circulating markers of abdominal aortic aneurysm presence and progression. Circulation 2008, 118:2382-2392.
19. Hellenthal F.A., Buurman W.A., Wodzig W.K., et al. Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. Nat Rev Cardiol 2009, 6:464-474.
20. Watanabe T., Sato A., Sawai T., et al. The elevated level of circulating matrix metalloproteinase-9 in patients with abdominal aortic aneurysms decreased to levels equal to those of health controls after an aortic repair. Ann Vasc Surg 2006, 20:317-321.
21. Eugster T., Huber A., Obeid T., et al. Aminoterminal propeptide of type III procollagen and matrix metalloproteinases-2 and -9 failed to serve as serum markers for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2005, 29:378-382.
22. van Laake L.W., Vainas T., Dammers R., et al. Systemic dilation diathesis in patients with abdominal aortic aneurysms: a role for matrix metalloproteinase-9?. Eur J Vasc Endovasc Surg 2005, 29:371-377.
23. Sangiorgi G., D'Averio R., Mauriello A., et al. Plasma levels of metalloprotienases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation 2001, 104(Suppl):I/288-I/295.
24. Hovespian D.M., Ziporin S.J., Sakurai M.K., et al. Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. J Vasc Interv Radiol 2000, 11:1345-1352.
25. McMillan W.D., Pearce W.H. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 1999, 29:122-127.
26. Wilson W.R., Choke E.C., Dawson J., et al. Plasma matrix metalloproteinase levels do not predict tissue levels in abdominal aortic aneurysm suitable for elective repair. Vascular 2008, 16(5):248-252.
27. Karlsson L., Bergqvist D., Lindback J., et al. Expansion of small-diameter abdominal aortic aneurysms is not reflected by the release of inflammatory mediators IL-6, MMP-9 and CRP in plasma. Eur J Vasc Endovasc Surg 2009, 37:420-424.
28. Lindholt J.S., Vammen S., Fasting H., et al. The plasma level of matrix metalloproteinase-9 may predict the natural history of small abdominal aortic aneurysms: a preliminary study. Eur J Vasc Endovasc Surg 2000, 20:281-285.
29. Wang Y., Barbacioru C.C., Shiffman D., et al. Gene expression signature in peripheral blood detects thoracic aortic aneurysm. PLoS One 2007, 2(10):e1050.
30. Elefteriades J.A. Future prospects: molecular diagnosis, enhanced imaging, molecular-based conventional drugs, and gene therapy. Acute aortic disease 2007, 347-351. Informa Healthcare, New York. J.A. Elefteriades (Ed.).
31. Treska V., Topolcan O., Pecen L. Cytokines as plasma markers of abdominal aortic aneurysm. Clin Chem Lab Med 2000, 38:1161-1164.
32. Sun J., Sukhova G.K., Yang M., et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest 2007, 117:3359-3368.
33. Walton L.J., Franklin I.J., Bayston T., et al. Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation 1999, 100:48-54.
34. Swartbol P., Truedsson L., Norgren L. Adverse reactions during endovascular treatment of aortic aneurysms may be triggered by interleukin 6 release from the thrombotic content. J Vasc Surg 1998, 28:664-668.
35. Jones K.G., Brull D.J., Brown L.C., et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001, 103:2260-2265.
36. Hellenthal F.A., Buurman W.A., Wodzig W.H., et al. Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation. Nat Rev Cardiol 2009, 6:543-552.
37. Juvonen J., Surcel H.M., Satta J., et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1997, 17:2843-2847.
38. Suzuki T. Cardiovascular diagnostic biomarkers: the past, present and future. Circ J 2009, 73:806-809.
39. Akutsu K., Sato N., Yamamoto T., et al. A rapid bedside D-dimer assay (cardiac D-dimer) for screening of clinically suspected acute aortic dissection. Circ J 2005, 69:397-403.
40. Hazui H., Nishimoto M., Hoshiga M., et al. Young adult patients with short dissection length and thrombosed false lumen without ulcer-like projections are liable to have false-negative results of D-dimer testing for acute aortic dissection based on a study of 113 cases. Circ J 2006, 70:1598-1601.
41. Wiegand J., Koller M., Bingisser R. Does a negative D-dimer test rule out aortic dissection?. Swiss Med Wkly 2007, 137:462.
42. Ohlmann P., Faure A., Morel O., et al. Diagnostic and prognostic value of circulating D-dimers in patients with acute aortic dissection. Crit Care Med 2006, 34:1358-1364.
43. Paparella D., Malvindi P.G., Scrascia G. D-dimers are not always elevated in patients with acute aortic dissection. J Cardiovasc Med 2009, 10:212-214.
44. Suzuki T., Distante A., Zizza A., et al. Diagnosis of acute aortic dissection by D-dimer. The International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience. Circulation 2009, 119:2702-2709.
45. Sbarouni E., Georgiadou P., Marathias A., et al. D-dimer and BNP levels in acute aortic dissection. Int J Cardiol 2007, 122:170-172.
46. Sodeck G., Domanovits H., Schillinger M. D-dimer in ruling out aortic dissection: a systematic review and prospective cohort study. Eur Heart J 2007, 28(24):3067-3075.
47. Sutherland A., Escano J., Coon T.P. D-dimer as the sole screening test for acute aortic dissection: a review of the literature. Ann Emerg Med 2008, 52:339-343.
48. Eggebrecht H., Naber C., Bruch C. Value of plasma fibrin D-dimers for detection of acute aortic dissection. J Am Coll Cardiol 2004, 44:804-809.
49. Hazui H., Fukumoto H., Negoro N., et al. Simple and useful tests for discriminating between acute aortic dissection of the ascending aorta and acute myocardial infarction in the emergency setting. Circ J 2005, 69:677-682.
50. Evangelista A., Mukherjee D., Mehta R.H., et al. Acute intramural hematoma of the aorta: a mystery in evolution. Circulation 2005, 111:1063-1070.